NZ is lagging well behind even poor nations when it comes to funding advanced cancer drugs. Australian researcher Professor John Zalcberg and Richard Vines from Rare Cancers Australia founder are part of the lobby group The Cancer Drugs Alliance in Austrlalia and say our government should invest in more treatments.
Recent stories from Sunday Morning
Get the RNZ app
for easy access to all your favourite programmes
